A clinical condition characterised by involuntary pelvic-floor muscle contraction at the prospect of vaginal penetration. The phenomenon is widely under-recognised, particularly in Japanese clinical contexts, with many affected women experiencing prolonged distress before reaching adequate diagnosis. Modern treatment combines pelvic-floor physical therapy with graduated dilator training and cognitive-behavioural intervention, with strong evidence for substantial improvement across the majority of cases.

Vaginismus (Japanese: 膣けいれん, chitsu-keiren; English: vaginismus, vaginal spasm; DSM-5: incorporated into genito-pelvic pain / penetration disorder, GPPPD) is the condition in which the pelvic-floor muscles surrounding the vaginal opening and the anterior-wall region (particularly the bulbocavernosus and superficial-perineal-transverse muscles) involuntarily contract and tense, rendering penetration during sexual intercourse — or insertion of any object (finger, tampon, vaginal speculum) — extremely difficult or impossible. The defining feature is that the affected person cannot voluntarily relax the muscles by conscious effort; the contraction is not intentional or volitional.

Distinction in vocabulary

The English-language vocabulary uses vaginismus as the clinical-and-everyday standard term, derived from Latin vagina + -ismus (Greek -ismos nominalising suffix). The term has been in established clinical use since the 19th century. The DSM-5 (2013) consolidation under genito-pelvic pain / penetration disorder (GPPPD) reflects the diagnostic-framework shift; vaginismus nonetheless remains the most-widely-used clinical-and-everyday term.

The Japanese-language vocabulary parallels with chitsu-keiren (膣けいれん, “vaginal spasm”) as the formal-clinical term and baginisumusu (バギニスムス, transliteration) as the loan-word variant. Sub-variant terminology chitsu-keiren-shō (膣けいれん症, “vaginal-spasm disease”) operates in slightly more clinical-emphatic register. The Japanese clinical vocabulary’s relative newness reflects the lower clinical-and-public-awareness of the condition in the Japanese context compared to Western clinical contexts.

Classification

Under DSM-IV, vaginismus was listed as an independent diagnostic entity. Under DSM-5 (2013), it was consolidated with dyspareunia into Genito-Pelvic Pain / Penetration Disorder (GPPPD). The diagnostic-framework change reflects the recognition that vaginismus and dyspareunia frequently co-occur and share overlapping aetiologies. However, in clinical and general-use vocabulary, vaginismus continues to be widely used as the standalone term.

Sub-classification by onset distinguishes primary (lifelong) vaginismus, present from before any sexual-intercourse experience, from secondary (acquired) vaginismus, developing after previous absence-of-problem. Sub-classification by extent distinguishes generalized vaginismus, occurring with any penetration attempt, from situational vaginismus, occurring only in specific contexts.

Aetiology and mechanism

The aetiology of vaginismus is complex and is not adequately explained by any single factor.

Psychological factors include fear-and-anxiety surrounding sexual intercourse, past sexual-trauma history (sexual assault, childhood sexual abuse), religious or cultural “sex-as-shame” framing, and excessive tension surrounding first sexual experience. A characteristic vicious cycle forms: “anticipation of pain → muscle tension → actual penetration-difficulty and pain → reinforcement of fear”.

Organic factors include congenital vaginal abnormality (septum, imperforate hymen), vulvar inflammation and vaginitis (candidal and others), vulvodynia, post-childbirth scar tissue, and endometriosis. Patterns in which organic-disease-induced pain conditions a reflexive muscle-tension response are also common.

Symptoms and life impact

Beyond the penetration difficulty itself, the condition produces strong anxiety-and-fear surrounding penetration attempts (avoidance behaviour), generalised fear of vaginal insertion (including strong resistance to gynaecological examination), and impact on partner relationship (guilt, self-loathing, relationship breakdown).

Women who continuously avoid gynaecological examination and cervical-cancer screening sometimes have undetected vaginismus underlying the avoidance. Overlap and comorbidity with dyspareunia is also common.

Recognition and access in Japan

In Japan, vaginismus recognition is low across gynaecology and sexual-medicine specialties, with relatively few medical facilities able to provide adequate diagnosis and treatment. Many affected women cannot openly discuss the “cannot have penetration” problem, with prolonged silent suffering accompanied by the mistaken self-perception of “being defective as a woman”.

Online communities and patient-support groups have driven recognition expansion from the 2010s onward, but the Japanese Society of Obstetrics and Gynecology has not yet established official clinical guidelines. The gap between Japanese and Western clinical-care availability remains substantial.

Treatment

Pelvic-floor physical therapy uses specialised physical-therapist guidance for biofeedback-based and relaxation-based pelvic-floor-muscle training. The approach has the strongest evidence base among vaginismus treatments and is the recommended first-line non-pharmacological intervention.

Dilator therapy uses silicone or similar-material graduated-size insertion devices, progressing from minimum size to gradually larger sizes, conditioning the pelvic-floor to tolerate vaginal insertion. The approach is self-administrable as home-based therapy and is widely-used.

Cognitive-behavioural therapy (CBT) targets the cognitive patterns of fear and avoidance surrounding penetration. The approach is effective as monotherapy but is recommended in combination with pelvic-floor training for most cases.

Pharmacological options are limited. Topical local-anaesthetic creams and topical muscle-relaxant applications have limited efficacy. For severe cases, botulinum toxin pelvic-floor-muscle injection has been reported as experimental treatment, with reasonable response rates in selected cases.

Cultural framing

Western clinical-context normalisation of vaginismus-treatment as routine sexual-medicine practice has developed substantially through the 2000s and 2010s, with established multi-disciplinary clinical pathways combining gynaecology, pelvic-floor physical therapy, and sex-therapy. Books such as When Sex Hurts (Goldstein, Pukall, and Goldstein, 2011) have provided patient-accessible framing of the condition.

The Japanese clinical-context lag in vaginismus-recognition reflects broader cultural factors: lower routine sexual-health-discussion in clinical contexts, more-restricted sexual-health-education curricula, and lower public-awareness of the condition as a recognised medical category. The 2010s onward has seen incremental Japanese-clinical-context improvement, with continued progress required.

Related Terms

• Vagina (chitsu)
• Dyspareunia
• Frigidity (fukansho)
• Orgasmic disorder
• Bartholin’s gland
• Couple sexuality